Subgroup analysis results revealed that regional factors exerted a significant influence on the efficacy of conventional probiotics in managing NAFLD/NASH patients, particularly with regards to ALT, AST, TC, TG, BMI, and Fibroscan CAP score indicators. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.